{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T10:33:52Z","timestamp":1750070032316,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s12033-023-00770-7","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T09:02:03Z","timestamp":1684746123000},"page":"475-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cuproptosis-Related Gene Signature Contributes to Prognostic Prediction and Immunosuppression in Multiple Myeloma"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3946-289X","authenticated-orcid":false,"given":"Huixin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szehoi","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"3","key":"770_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.soncn.2017.05.012","volume":"33","author":"K Brigle","year":"2017","unstructured":"Brigle, K., & Rogers, B. (2017). Pathobiology and diagnosis of multiple myeloma. Seminars in Oncology Nursing, 33(3), 225\u2013236. https:\/\/doi.org\/10.1016\/j.soncn.2017.05.012","journal-title":"Seminars in Oncology Nursing"},{"issue":"6","key":"770_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","volume":"43","author":"D Kazandjian","year":"2016","unstructured":"Kazandjian, D. (2016). Multiple myeloma epidemiology and survival: A unique malignancy. Seminars in Oncology, 43(6), 676\u2013681. https:\/\/doi.org\/10.1053\/j.seminoncol.2016.11.004","journal-title":"Seminars in Oncology"},{"key":"770_CR3","doi-asserted-by":"publisher","first-page":"102284","DOI":"10.1016\/j.ctrv.2021.102284","volume":"100","author":"P Rodriguez-Otero","year":"2021","unstructured":"Rodriguez-Otero, P., Paiva, B., & San-Miguel, J. F. (2021). Roadmap to cure multiple myeloma. Cancer Treat Rev, 100, 102284. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102284","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"770_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1158\/2643-3230.Bcd-21-0205","volume":"3","author":"FE Davies","year":"2022","unstructured":"Davies, F. E., Pawlyn, C., Usmani, S. Z., San-Miguel, J. F., Einsele, H., Boyle, E. M., Corre, J., Auclair, D., Cho, H. J., Lonial, S., et al. (2022). Perspectives on the risk-stratified treatment of multiple myeloma. Blood Cancer Discov, 3(4), 273\u2013284. https:\/\/doi.org\/10.1158\/2643-3230.Bcd-21-0205","journal-title":"Blood Cancer Discov"},{"issue":"2","key":"770_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge, E. J., Bush, A. I., Casini, A., Cobine, P. A., Cross, J. R., DeNicola, G. M., Dou, Q. P., Franz, K. J., Gohil, V. M., Gupta, S., et al. (2022). Connecting copper and cancer: From transition metal signalling to metalloplasia. Nature Reviews Cancer, 22(2), 102\u2013113. https:\/\/doi.org\/10.1038\/s41568-021-00417-2","journal-title":"Nature Reviews Cancer"},{"key":"770_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2200554","author":"Q Xue","year":"2023","unstructured":"Xue, Q., Kang, R., Klionsky, D. J., Tang, D., Liu, J., & Chen, X. (2023). Copper metabolism in cell death and autophagy. Autophagy. https:\/\/doi.org\/10.1080\/15548627.2023.2200554","journal-title":"Autophagy"},{"key":"770_CR7","doi-asserted-by":"publisher","DOI":"10.1515\/9783110527872-018","author":"J Lopez","year":"2019","unstructured":"Lopez, J., Ramchandani, D., & Vahdat, L. (2019). Copper depletion as a therapeutic strategy in cancer. Met Ions Life Sci. https:\/\/doi.org\/10.1515\/9783110527872-018","journal-title":"Met Ions Life Sci"},{"issue":"1","key":"770_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/0019-509x.175573","volume":"52","author":"ML Adeoti","year":"2015","unstructured":"Adeoti, M. L., Oguntola, A. S., Akanni, E. O., Agodirin, O. S., & Oyeyemi, G. M. (2015). Trace elements; copper, zinc and selenium, in breast cancer afflicted female patients in LAUTECH Osogbo Nigeria. Indian Journal of Cancer, 52(1), 106\u2013109. https:\/\/doi.org\/10.4103\/0019-509x.175573","journal-title":"Indian Journal of Cancer"},{"issue":"4","key":"770_CR9","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/1097-0142(19890215)63:4<726::aid-cncr2820630421>3.0.co;2-p","volume":"63","author":"M D\u00ecez","year":"1989","unstructured":"D\u00ecez, M., Cerd\u00e0n, F. J., Arroyo, M., & Balibrea, J. L. (1989). Use of the copper\/zinc ratio in the diagnosis of lung cancer. Cancer, 63(4), 726\u2013730. https:\/\/doi.org\/10.1002\/1097-0142(19890215)63:4%3c726::aid-cncr2820630421%3e3.0.co;2-p","journal-title":"Cancer"},{"issue":"7","key":"770_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/carcin\/bgx051","volume":"38","author":"M Stepien","year":"2017","unstructured":"Stepien, M., Jenab, M., Freisling, H., Becker, N. P., Czuban, M., Tj\u00f8nneland, A., Olsen, A., Overvad, K., Boutron-Ruault, M. C., Mancini, F. R., et al. (2017). Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Carcinogenesis, 38(7), 699\u2013707. https:\/\/doi.org\/10.1093\/carcin\/bgx051","journal-title":"Carcinogenesis"},{"issue":"1","key":"770_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000499261","volume":"14","author":"SAK Saleh","year":"2020","unstructured":"Saleh, S. A. K., Adly, H. M., Abdelkhaliq, A. A., & Nassir, A. M. (2020). Serum levels of selenium, zinc, copper, manganese, and iron in prostate cancer patients. Current Urology, 14(1), 44\u201349. https:\/\/doi.org\/10.1159\/000499261","journal-title":"Current Urology"},{"issue":"5","key":"770_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2217\/nnm-2021-0374","volume":"17","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y., Huo, Z., Qi, X., Zuo, T., & Wu, Z. (2022). Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes. Nanomedicine (London, England), 17(5), 303\u2013324. https:\/\/doi.org\/10.2217\/nnm-2021-0374","journal-title":"Nanomedicine (London, England)"},{"issue":"6","key":"770_CR13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.drudis.2020.04.003","volume":"25","author":"H Li","year":"2020","unstructured":"Li, H., Wang, J., Wu, C., Wang, L., Chen, Z. S., & Cui, W. (2020). The combination of disulfiram and copper for cancer treatment. Drug Discovery Today, 25(6), 1099\u20131108. https:\/\/doi.org\/10.1016\/j.drudis.2020.04.003","journal-title":"Drug Discovery Today"},{"key":"770_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030644","author":"C Weyh","year":"2022","unstructured":"Weyh, C., Kr\u00fcger, K., Peeling, P., & Castell, L. (2022). The role of minerals in the optimal functioning of the immune system. Nutrients. https:\/\/doi.org\/10.3390\/nu14030644","journal-title":"Nutrients"},{"key":"770_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4613-0537-8_22","volume":"258","author":"JR Stabel","year":"1989","unstructured":"Stabel, J. R., & Spears, J. W. (1989). Effect of copper on immune function and disease resistance. Advances in Experimental Medicine and Biology, 258, 243\u2013252. https:\/\/doi.org\/10.1007\/978-1-4613-0537-8_22","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"19","key":"770_CR16","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1158\/0008-5472.Can-20-0471","volume":"80","author":"F Voli","year":"2020","unstructured":"Voli, F., Valli, E., Lerra, L., Kimpton, K., Saletta, F., Giorgi, F. M., Mercatelli, D., Rouaen, J. R. C., Shen, S., Murray, J. E., et al. (2020). Intratumoral copper modulates PD-L1 Expression and Influences Tumor Immune Evasion. Cancer Research, 80(19), 4129\u20134144. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0471","journal-title":"Cancer Research"},{"issue":"6586","key":"770_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., Rossen, J., Joesch-Cohen, L., Humeidi, R., Spangler, R. D., et al. (2022). Copper induces cell death by targeting lipoylated TCA cycle proteins. Science, 375(6586), 1254\u20131261. https:\/\/doi.org\/10.1126\/science.abf0529","journal-title":"Science"},{"issue":"5","key":"770_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","volume":"32","author":"D Tang","year":"2022","unstructured":"Tang, D., Chen, X., & Kroemer, G. (2022). Cuproptosis: A copper-triggered modality of mitochondrial cell death. Cell Research, 32(5), 417\u2013418. https:\/\/doi.org\/10.1038\/s41422-022-00653-7","journal-title":"Cell Research"},{"key":"770_CR19","doi-asserted-by":"publisher","first-page":"8489387","DOI":"10.1155\/2022\/8489387","volume":"2022","author":"J Han","year":"2022","unstructured":"Han, J., Hu, Y., Liu, S., Jiang, J., & Wang, H. (2022). A newly established cuproptosis-associated long non-coding RNA signature for predicting prognosis and indicating immune microenvironment features in soft tissue sarcoma. Journal of Oncology, 2022, 8489387. https:\/\/doi.org\/10.1155\/2022\/8489387","journal-title":"Journal of Oncology"},{"key":"770_CR20","doi-asserted-by":"publisher","first-page":"996836","DOI":"10.3389\/fimmu.2022.996836","volume":"13","author":"Z Li","year":"2022","unstructured":"Li, Z., Zhang, H., Wang, X., Wang, Q., Xue, J., Shi, Y., Wang, M., Wang, G., & Zhang, J. (2022). Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer. Frontiers in Immunology, 13, 996836. https:\/\/doi.org\/10.3389\/fimmu.2022.996836","journal-title":"Frontiers in Immunology"},{"key":"770_CR21","doi-asserted-by":"publisher","first-page":"930041","DOI":"10.3389\/fphar.2022.930041","volume":"13","author":"H Lv","year":"2022","unstructured":"Lv, H., Liu, X., Zeng, X., Liu, Y., Zhang, C., Zhang, Q., & Xu, J. (2022). Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in melanoma. Frontiers in Pharmacology, 13, 930041. https:\/\/doi.org\/10.3389\/fphar.2022.930041","journal-title":"Frontiers in Pharmacology"},{"key":"770_CR22","doi-asserted-by":"publisher","first-page":"110048","DOI":"10.1016\/j.biopha.2020.110048","volume":"126","author":"Y Xu","year":"2020","unstructured":"Xu, Y., Zhou, Q., Feng, X., Dai, Y., Jiang, Y., Jiang, W., Liu, X., Xing, X., Wang, Y., Ni, Y., et al. (2020). Disulfiram\/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways. Biomedicine & Pharmacotherapy, 126, 110048. https:\/\/doi.org\/10.1016\/j.biopha.2020.110048","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"770_CR23","doi-asserted-by":"publisher","first-page":"e0262212","DOI":"10.1371\/journal.pone.0262212","volume":"17","author":"A Agarwal","year":"2022","unstructured":"Agarwal, A., Khandelwal, A., Pal, K., Khare, N. K., Jadhav, V., Gurjar, M., Punatar, S., Gokarn, A., Bonda, A., Nayak, L., et al. (2022). A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001). PLoS One, 17(2), e0262212. https:\/\/doi.org\/10.1371\/journal.pone.0262212","journal-title":"PLoS One"},{"key":"770_CR24","doi-asserted-by":"publisher","first-page":"731957","DOI":"10.3389\/fonc.2021.731957","volume":"11","author":"R Liu","year":"2021","unstructured":"Liu, R., Shen, Y., Hu, J., Wang, X., Wu, D., Zhai, M., Bai, J., & He, A. (2021). Comprehensive analysis of m6A RNA methylation Regulators in the prognosis and immune microenvironment of multiple myeloma. Frontiers in Oncology, 11, 731957. https:\/\/doi.org\/10.3389\/fonc.2021.731957","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"770_CR25","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T., Hu, E., Xu, S., Chen, M., Guo, P., Dai, Z., Feng, T., Zhou, L., Tang, W., Zhan, L., et al. (2021). clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The Innovation (Camb), 2(3), 100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","journal-title":"The Innovation (Camb)"},{"issue":"1","key":"770_CR26","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1038\/s41467-018-07767-w","volume":"9","author":"Q Jia","year":"2018","unstructured":"Jia, Q., Wu, W., Wang, Y., Alexander, P. B., Sun, C., Gong, Z., Cheng, J. N., Sun, H., Guan, Y., Xia, X., et al. (2018). Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nature Communications, 9(1), 5361. https:\/\/doi.org\/10.1038\/s41467-018-07767-w","journal-title":"Nature Communications"},{"issue":"1","key":"770_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017). Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Reports, 18(1), 248\u2013262. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019","journal-title":"Cell Reports"},{"issue":"1","key":"770_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13045-021-01162-7","volume":"14","author":"CT Wallington-Beddoe","year":"2021","unstructured":"Wallington-Beddoe, C. T., & Mynott, R. L. (2021). Prognostic and predictive biomarker developments in multiple myeloma. Journal of Hematology & Oncology, 14(1), 151. https:\/\/doi.org\/10.1186\/s13045-021-01162-7","journal-title":"Journal of Hematology & Oncology"},{"issue":"11","key":"770_CR29","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1101\/gr.189597.115","volume":"25","author":"T Szczepi\u0144ska","year":"2015","unstructured":"Szczepi\u0144ska, T., Kalisiak, K., Tomecki, R., Labno, A., Borowski, L. S., Kulinski, T. M., Adamska, D., Kosinska, J., & Dziembowski, A. (2015). DIS3 shapes the RNA polymerase II transcriptome in humans by degrading a variety of unwanted transcripts. Genome Research, 25(11), 1622\u20131633. https:\/\/doi.org\/10.1101\/gr.189597.115","journal-title":"Genome Research"},{"issue":"10","key":"770_CR30","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1158\/1078-0432.Ccr-19-1507","volume":"26","author":"EM Boyle","year":"2020","unstructured":"Boyle, E. M., Ashby, C., Tytarenko, R. G., Deshpande, S., Wang, H., Wang, Y., Rosenthal, A., Sawyer, J., Tian, E., Flynt, E., et al. (2020). BRAF and DIS3 mutations associate with adverse outcome in a long-term follow-up of patients with multiple myeloma. Clinical Cancer Research, 26(10), 2422\u20132432. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-1507","journal-title":"Clinical Cancer Research"},{"key":"770_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115652","author":"J Zhu","year":"2021","unstructured":"Zhu, J., Kong, W., & Xie, Z. (2021). Expression and prognostic characteristics of ferroptosis-related genes in colon cancer. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms22115652","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"770_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov, P., Detappe, A., Cai, K., Keys, H. R., Brune, Z., Ying, W., Thiru, P., Reidy, M., Kugener, G., Rossen, J., et al. (2019). Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nature Chemical Biology, 15(7), 681\u2013689. https:\/\/doi.org\/10.1038\/s41589-019-0291-9","journal-title":"Nature Chemical Biology"},{"issue":"6","key":"770_CR33","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cmet.2016.08.017","volume":"24","author":"JD Arroyo","year":"2016","unstructured":"Arroyo, J. D., Jourdain, A. A., Calvo, S. E., Ballarano, C. A., Doench, J. G., Root, D. E., & Mootha, V. K. (2016). A genome-wide CRISPR death screen identifies genes essential for oxidative phosphorylation. Cell Metabolism, 24(6), 875\u2013885. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.017","journal-title":"Cell Metabolism"},{"key":"770_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.freeradbiomed.2020.11.037","volume":"162","author":"S Yumnam","year":"2021","unstructured":"Yumnam, S., Kang, M. C., Oh, S. H., Kwon, H. C., Kim, J. C., Jung, E. S., Lee, C. H., Lee, A. Y., Hwang, J. I., & Kim, S. Y. (2021). Downregulation of dihydrolipoyl dehydrogenase by UVA suppresses melanoma progression via triggering oxidative stress and altering energy metabolism. Free Radical Biology & Medicine, 162, 77\u201387. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.11.037","journal-title":"Free Radical Biology & Medicine"},{"key":"770_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040762","author":"EV Prochownik","year":"2021","unstructured":"Prochownik, E. V., & Wang, H. (2021). The metabolic fates of pyruvate in normal and neoplastic cells. Cells. https:\/\/doi.org\/10.3390\/cells10040762","journal-title":"Cells"},{"key":"770_CR36","doi-asserted-by":"publisher","first-page":"947372","DOI":"10.3389\/fphar.2022.947372","volume":"13","author":"L Deng","year":"2022","unstructured":"Deng, L., Jiang, A., Zeng, H., Peng, X., & Song, L. (2022). Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer. Frontiers in Pharmacology, 13, 947372. https:\/\/doi.org\/10.3389\/fphar.2022.947372","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"770_CR37","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1200\/jco.1998.16.3.1197","volume":"16","author":"WH Liggett Jr","year":"1998","unstructured":"Liggett, W. H., Jr., & Sidransky, D. (1998). Role of the p16 tumor suppressor gene in cancer. Journal of Clinical Oncology, 16(3), 1197\u20131206. https:\/\/doi.org\/10.1200\/jco.1998.16.3.1197","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"770_CR38","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/00000658-200212000-00005","volume":"236","author":"DK Bartsch","year":"2002","unstructured":"Bartsch, D. K., Sina-Frey, M., Lang, S., Wild, A., Gerdes, B., Barth, P., Kress, R., Gr\u00fctzmann, R., Colombo-Benkmann, M., Ziegler, A., et al. (2002). CDKN2A germline mutations in familial pancreatic cancer. Annals of Surgery, 236(6), 730\u2013737. https:\/\/doi.org\/10.1097\/00000658-200212000-00005","journal-title":"Annals of Surgery"},{"issue":"3","key":"770_CR39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers, P., Hielscher, T., Schrimpf, D., Stichel, D., Reuss, D. E., Berghoff, A. S., Neidert, M. C., Wirsching, H. G., Mawrin, C., Ketter, R., et al. (2020). CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathologica, 140(3), 409\u2013413. https:\/\/doi.org\/10.1007\/s00401-020-02188-w","journal-title":"Acta Neuropathologica"},{"issue":"5","key":"770_CR40","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3892\/etm.2017.4274","volume":"13","author":"D Mart\u00ednez-Ba\u00f1os","year":"2017","unstructured":"Mart\u00ednez-Ba\u00f1os, D., S\u00e1nchez-Hern\u00e1ndez, B., Jim\u00e9nez, G., Barrera-Lumbreras, G., & Barrales-Ben\u00edtez, O. (2017). Global methylation and promoter-specific methylation of the P16, SOCS-1, E-cadherin, P73 and SHP-1 genes and their expression in patients with multiple myeloma during active disease and remission. Experimental and Therapeutic Medicine, 13(5), 2442\u20132450. https:\/\/doi.org\/10.3892\/etm.2017.4274","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"4","key":"770_CR41","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1046\/j.1365-2141.2002.03749.x","volume":"118","author":"MV Mateos","year":"2002","unstructured":"Mateos, M. V., Garc\u00eda-Sanz, R., L\u00f3pez-P\u00e9rez, R., Moro, M. J., Ocio, E., Hern\u00e1ndez, J., Megido, M., Caballero, M. D., Fern\u00e1ndez-Calvo, J., B\u00e1rez, A., et al. (2002). Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival. British Journal of Haematology, 118(4), 1034\u20131040. https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03749.x","journal-title":"British Journal of Haematology"},{"issue":"1","key":"770_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00277-010-1043-9","volume":"90","author":"G Park","year":"2011","unstructured":"Park, G., Kang, S. H., Lee, J. H., Suh, C., Kim, M., Park, S. M., Kim, T. Y., Oh, B., Min, H. J., Yoon, S. S., et al. (2011). Concurrent p16 methylation pattern as an adverse prognostic factor in multiple myeloma: A methylation-specific polymerase chain reaction study using two different primer sets. Annals of Hematology, 90(1), 73\u201379. https:\/\/doi.org\/10.1007\/s00277-010-1043-9","journal-title":"Annals of Hematology"},{"issue":"5","key":"770_CR43","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1182\/blood.V95.5.1869.005k09_1869_1871","volume":"95","author":"D Dilworth","year":"2000","unstructured":"Dilworth, D., Liu, L., Stewart, A. K., Berenson, J. R., Lassam, N., & Hogg, D. (2000). Germline CDKN2A mutation implicated in predisposition to multiple myeloma. Blood, 95(5), 1869\u20131871.","journal-title":"Blood"},{"key":"770_CR44","doi-asserted-by":"publisher","first-page":"12050","DOI":"10.1038\/ncomms12050","volume":"7","author":"JS Mitchell","year":"2016","unstructured":"Mitchell, J. S., Li, N., Weinhold, N., F\u00f6rsti, A., Ali, M., van Duin, M., Thorleifsson, G., Johnson, D. C., Chen, B., Halvarsson, B. M., et al. (2016). Genome-wide association study identifies multiple susceptibility loci for multiple myeloma. Nature Communications, 7, 12050. https:\/\/doi.org\/10.1038\/ncomms12050","journal-title":"Nature Communications"},{"issue":"1","key":"770_CR45","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1186\/s12885-017-3715-5","volume":"17","author":"V Shah","year":"2017","unstructured":"Shah, V., Boyd, K. D., Houlston, R. S., & Kaiser, M. F. (2017). Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: A case report. BMC Cancer, 17(1), 718. https:\/\/doi.org\/10.1186\/s12885-017-3715-5","journal-title":"BMC Cancer"},{"key":"770_CR46","doi-asserted-by":"publisher","first-page":"101406","DOI":"10.1016\/j.smim.2020.101406","volume":"48","author":"C Saut\u00e8s-Fridman","year":"2020","unstructured":"Saut\u00e8s-Fridman, C., Verneau, J., Sun, C. M., Moreira, M., Chen, T. W., Meylan, M., Petitprez, F., & Fridman, W. H. (2020). Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer. Seminars in Immunology, 48, 101406. https:\/\/doi.org\/10.1016\/j.smim.2020.101406","journal-title":"Seminars in Immunology"},{"issue":"1","key":"770_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/nyas.14377","volume":"1499","author":"M Lopez-Yrigoyen","year":"2021","unstructured":"Lopez-Yrigoyen, M., Cassetta, L., & Pollard, J. W. (2021). Macrophage targeting in cancer. Annals of the New York Academy of Sciences, 1499(1), 18\u201341. https:\/\/doi.org\/10.1111\/nyas.14377","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"25","key":"770_CR48","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","volume":"184","author":"C Cui","year":"2021","unstructured":"Cui, C., Wang, J., Fagerberg, E., Chen, P. M., Connolly, K. A., Damo, M., Cheung, J. F., Mao, T., Askari, A. S., Chen, S., et al. (2021). Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses. Cell, 184(25), 6101-6118.e6113. https:\/\/doi.org\/10.1016\/j.cell.2021.11.007","journal-title":"Cell"},{"issue":"12","key":"770_CR49","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes, J., Jongsma, M. L., Paul, P., & Bakke, O. (2011). Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nature Reviews Immunology, 11(12), 823\u2013836. https:\/\/doi.org\/10.1038\/nri3084","journal-title":"Nature Reviews Immunology"},{"issue":"17","key":"770_CR50","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2174\/0929867324666170804143706","volume":"26","author":"B Li","year":"2019","unstructured":"Li, B., Chan, H. L., & Chen, P. (2019). Immune checkpoint inhibitors: Basics and challenges. Current Medicinal Chemistry, 26(17), 3009\u20133025. https:\/\/doi.org\/10.2174\/0929867324666170804143706","journal-title":"Current Medicinal Chemistry"},{"key":"770_CR51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.canlet.2021.04.021","volume":"511","author":"G Wei","year":"2021","unstructured":"Wei, G., Zhang, H., Zhao, H., Wang, J., Wu, N., Li, L., Wu, J., & Zhang, D. (2021). Emerging immune checkpoints in the tumor microenvironment: Implications for cancer immunotherapy. Cancer Letters, 511, 68\u201376. https:\/\/doi.org\/10.1016\/j.canlet.2021.04.021","journal-title":"Cancer Letters"},{"issue":"10","key":"770_CR52","doi-asserted-by":"publisher","first-page":"153114","DOI":"10.1016\/j.prp.2020.153114","volume":"216","author":"S Caserta","year":"2020","unstructured":"Caserta, S., Innao, V., Musolino, C., & Allegra, A. (2020). Immune checkpoint inhibitors in multiple myeloma: A review of the literature. Pathology Research and Practice, 216(10), 153114. https:\/\/doi.org\/10.1016\/j.prp.2020.153114","journal-title":"Pathology Research and Practice"},{"issue":"1","key":"770_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13045-020-00947-6","volume":"13","author":"B Salik","year":"2020","unstructured":"Salik, B., Smyth, M. J., & Nakamura, K. (2020). Targeting immune checkpoints in hematological malignancies. Journal of Hematology & Oncology, 13(1), 111. https:\/\/doi.org\/10.1186\/s13045-020-00947-6","journal-title":"Journal of Hematology & Oncology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00770-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00770-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00770-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T08:15:46Z","timestamp":1708848946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00770-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["770"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00770-7","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"type":"print","value":"1073-6085"},{"type":"electronic","value":"1559-0305"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"14 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}